The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3′,5′-Cyclic Monophosphate
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Shillingford, J. M., Murcia, N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., Flask, C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509694103 · Cited by 808
Ward, C. J., Hogan, M. C., Rossetti, S., Walker, D., Sneddon, T., Wang, X., Kubly, V., Cunningham, J. M., Bacallao, R., Ishibashi, M., et al. (2002) · Nature Genetics · doi:10.1038/ng833 · Cited by 765
Self-citationGattone, V. H., Wang, X., Harris, P. C., & Torres, V. E. (2003) · Nature Medicine · doi:10.1038/nm935 · Cited by 670
Self-citationOnuchic, L. F., Furu, L., Nagasawa, Y., Hou, X., Eggermann, T., Ren, Z., Bergmann, C., Senderek, J., Esquivel, E., Zeltner, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340448 · Cited by 508
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Torres, V. E., Wang, X., Qian, Q., Somlo, S., Harris, P. C., & Gattone, V. H. (2004) · Nature Medicine · doi:10.1038/nm1004 · Cited by 482
Self-citationRegulation and function of somatostatin receptors
Olias, G., Viollet, C., Kusserow, H., Epelbaum, J., & Meyerhof, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02402.x · Cited by 318
Møller, L. N., Stidsen, C. E., Hartmann, B., & Holst, J. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00235-9 · Cited by 307
Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells
Belibi, F. A., Reif, G., Wallace, D. P., Yamaguchi, T., Olsen, L., Li, H., Helmkamp, G. M., & Grantham, J. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00843.x · Cited by 295
Wahl, P. R., Serra, A. L., Le Hir, M., Molle, K. D., Hall, M. N., & Wüthrich, R. P. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi181 · Cited by 287
Mutations in SEC63 cause autosomal dominant polycystic liver disease
Davila, S., Furu, L., Gharavi, A. G., Tian, X., Onoe, T., Qian, Q., Li, A., Cai, Y., Kamath, P. S., King, B. F., et al. (2004) · Nature Genetics · doi:10.1038/ng1357 · Cited by 286
Self-citationcAMP Regulates Cell Proliferation and Cyst Formation in Autosomal Polycystic Kidney Disease Cells
HANAOKA, K., & GUGGINO, W. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1171179 · Cited by 281
Adeva, M., El-Youssef, M., Rossetti, S., Kamath, P. S., Kubly, V., Consugar, M. B., Milliner, D. M., King, B. F., Torres, V. E., & Harris, P. C. (2006) · Medicine · doi:10.1097/01.md.0000200165.90373.9a · Cited by 273
Self-citationRuggenenti, P., Remuzzi, A., Ondei, P., Fasolini, G., Antiga, L., Ene-Iordache, B., Remuzzi, G., & Epstein, F. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00395.x · Cited by 270
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor
Sweeney, W. E., Chen, Y., Nakanishi, K., Frost, P., & Avner, E. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00829.x · Cited by 219
Masyuk, T. V., Huang, B. Q., Ward, C. J., Masyuk, A. I., Yuan, D., Splinter, P. L., Punyashthiti, R., Ritman, E. L., Torres, V. E., Harris, P. C., et al. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.09.001 · Cited by 209
Self-citationRichards, W. G., Sweeney, W. E., Yoder, B. K., Wilkinson, J. E., Woychik, R. P., & Avner, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2071 · Cited by 197
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease
Li, A., Davila, S., Furu, L., Qian, Q., Tian, X., Kamath, P. S., King, B. F., Torres, V. E., & Somlo, S. (2003) · The American Journal of Human Genetics · doi:10.1086/368295 · Cited by 193
Self-citationMarinelli, R. A., Pham, L., Agre, P., & LaRusso, N. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12984 · Cited by 186
Self-citationPolycystic disease of the liver
Everson, G. T., Taylor, M. R. G., & Doctor, B. R. (2004) · Hepatology · doi:10.1002/hep.1840400404 · Cited by 185
The genetics and physiology of polycystic kidney disease
Calvet, J. P., & Grantham, J. J. (2001) · Seminars in Nephrology · doi:10.1053/snep.2001.20929 · Cited by 163
Fabris, L., Cadamuro, M., Fiorotto, R., Roskams, T., Spirlì, C., Melero, S., Sonzogni, A., Joplin, R., Okolicsànyi, L., & Strazzabosco, M. (2006) · Hepatology · doi:10.1002/hep.21143 · Cited by 158
Liver Involvement in Autosomal-Dominant Polycystic Kidney Disease: Therapeutic Dilemma
Chauveau, D., Fakhouri, F., & Grünfeld, J. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191767 · Cited by 144
Francis, H., Glaser, S. S., Ueno, Y., LeSage, G., Marucci, L., Benedetti, A., Taffetani, S., Marzioni, M., Alvaro, D., Venter, J. K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.009 · Cited by 138
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00256.x · Cited by 135
Self-citationLahlou, H., Saint‐Laurent, N., Estève, J., Eychène, A., Pradayrol, L., Pyronnet, S., & Susini, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304524200 · Cited by 126
Imam, H., Eriksson, B. K., Lukinius, A., Janson, E. T., Lindgren, P.-G., Wilander, E., & Öberg, K. (1997) · Acta Oncologica · doi:10.3109/02841869709001323 · Cited by 113
Regulation and deregulation of cholangiocyte proliferation
Alvaro, D., Gigliozzi, A., & Attili, A. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80377-3 · Cited by 112
Masyuk, T. V., Huang, B. Q., Masyuk, A. I., Ritman, E. L., Torres, V. E., Wang, X., Harris, P. C., & LaRusso, N. F. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63427-x · Cited by 109
Self-citationReynolds, D. M., Falk, C. T., Li, A., King, B. F., Kamath, P. S., Huston, J., Shub, C., Iglesias, D. M., Martín, R. S., Pirson, Y., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316904 · Cited by 101
Self-citationNichols, M. T., Gidey, E., Matzakos, T., Dahl, R., Stiegmann, G. V., Shah, R. J., Grantham, J. J., Fitz, G. J., & Brian, R. (2004) · Hepatology · doi:10.1002/hep.1840400413 · Cited by 85
Molecular genetics of autosomal recessive polycystic kidney disease
Harris, P. C., & Rossetti, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.10.010 · Cited by 82
Self-citationEpidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00952.x · Cited by 79
Self-citationRoberts, S. K., Kuntz, S. M., Gores, G. J., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9080 · Cited by 74
Jakobs, K. H., Gehring, U., GAUGLER, B., Pfeuffer, T., & Schultz, G. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07192.x · Cited by 69
Drenth, J. P. H., Martina, J. A., Morsche, R. H. M. T., Jansen, J. B. �. �., & Bonifacino, J. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.023 · Cited by 62
Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy
Harris, P. C., & Torres, V. E. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000232888.65895.e7 · Cited by 39
Self-citationPolycystic liver disease: New insights into disease pathogenesis
Masyuk, T. V., & LaRusso, N. F. (2006) · Hepatology · doi:10.1002/hep.21199 · Cited by 36
Self-citationRegulated vesicle trafficking of membrane transporters in hepatic epithelia
Marinelli, R. A., Tietz, P. S., & LaRusso, N. F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.001 · Cited by 20
Self-citationTaffetani, S., Ueno, Y., Meng, F., Venter, J. K., Francis, H., Glaser, S. S., Alpini, G. D., & Patel, T. C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62477-7 · Cited by 20
Cited by
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Self-citationCiliopathies: an expanding disease spectrum
Waters, A. M., & Beales, P. L. (2011) · Pediatric Nephrology · doi:10.1007/s00467-010-1731-7 · Cited by 676
Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System
Thoolen, B., Maronpot, R. R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Malarkey, D. E., Kaufmann, W., Küttler, K., Deschl, U., et al. (2010) · Toxicologic Pathology · doi:10.1177/0192623310386499 · Cited by 631
Autosomal dominant polycystic kidney disease: the last 3 years
Torres, V. E., & Harris, P. C. (2009) · Kidney International · doi:10.1038/ki.2009.128 · Cited by 590
Self-citation
Metadata
- Authors
- Masyuk, T. V., Masyuk, A. I., Torres, V. E., Harris, P. C., & Larusso, N. F.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 132
- Issue
- 3
- Pages
- 1104-1116
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2151925930
- Cited by
- 283
- References
- 41
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.